EnsoData announced today that it closed a $9 million Series A financing round.

According to a release, the funds will be used to launch new AI products in sleep and neurology, grow the company’s team, expand diagnostic access and partnerships and extend support for clinical trials.

Venture Investors and Zetta Venture Partners led the round.

As previously reported, EnsoData is a graduate of gener8tor’s gBETA program.